What Are The Forecasted Market Sizes And Growth Rates For The Global Point-Of-Care Molecular Diagnostics Market?
The point-of-care molecular diagnostics market size has shown rapid growth in recent years, increasing from $3.55 billion in 2024 to $4.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. This growth in the historic period can be attributed to the rising demand for rapid disease diagnosis, growth in infectious disease outbreaks, expansion of telemedicine and remote testing, regulatory support for point-of-care diagnostics, and the pressing need for personalized precision medicine.
The point-of-care molecular diagnostics market size is expected to see rapid growth in the coming years, estimated to increase to $7.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. Growth in the forecasted period can be attributed to the miniaturization of diagnostic devices, expansion of POC testing for cancer and genetic diseases, customized molecular diagnostics for diverse applications, integration of AI and machine learning data analysis, and emerging infectious disease surveillance.
Get Your Free Sample of The Global Point-Of-Care Molecular Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp
What Factors Are Driving The Point-Of-Care Molecular Diagnostics Market Growth?
The rapid rise in the occurrence of infectious and respiratory diseases significantly contributes to the growth of the point-of-care molecular diagnostics market. Respiratory infections, such as viruses or bacteria, influence the respiratory system and are transferred through coughing, sneezing, or direct touch. Inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostics are some of the medical treatments utilized for such conditions. For instance, towards the end of 2022, the infection rates climbed for people aged 35 to 69 years and those in school years 12 to 24 years in England. Hence, the rapid occurrence of infectious and respiratory diseases and deaths will drive the point-of-care molecular diagnostics market.
What Are the Critical Segments Within the Global Point-Of-Care Molecular Diagnostics Market?
1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services
2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing
3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology
4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Order your report now for swift delivery:
Which Major Players Are Operating In The Point-Of-Care Molecular Diagnostics Market?
Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc..
Which Emerging Trends Are Changing The Point-Of-Care Molecular Diagnostics Market Landscape?
Technological innovation is an emerging trend gaining popularity in the point-of-care molecular diagnostics market. Companies are implementing advanced solutions including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and POC devices designed to accelerate analysis times and lower costs. One example is the US-based Sensible Diagnostics, which launched a 10-minute point-of-care PCR system in May 2023.
Which Region Is Embarking on The Fastest Growth In The Point-Of-Care Molecular Diagnostics Market?
North America was the largest region in the point-of-care molecular diagnostics market in 2024. Forecasted to be the fastest-growing region, Asia-Pacific’s development will contribute significantly to the global point-of-care molecular diagnostics market. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Point-Of-Care Molecular Diagnostics Market Report 2025 Offer?
The Point-Of-Care Molecular Diagnostics Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a variety of clinical specimens such as feces, saliva, urine, blood, and tissue. These are based on detecting targeted portions of microbial genetic material, DNA or RNA, and are utilized by the healthcare sector to diagnose diseases, including the detection of disease antigens or antibodies.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company,
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293,
Email: [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
Facebook: https://www.facebook.com/TheBusinessResearchCompany,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ,
Blog: https://blog.tbrc.info/,
Healthcare Blog: https://healthcareresearchreports.com/,
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model.
